Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial
Top Cited Papers
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9242) , 1638-1642
- https://doi.org/10.1016/s0140-6736(00)03157-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Stiripentol: Efficacy and Tolerability in Children with EpilepsyEpilepsia, 1999
- Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind studyThe Lancet, 1999
- A double-blind, randomized trial of topiramate in Lennox–Gastaut syndromeNeurology, 1999
- Lamotrigine and Seizure Aggravation in Severe Myoclonic EpilepsyEpilepsia, 1998
- Lamotrigine for Generalized Seizures Associated with the Lennox–Gastaut SyndromeNew England Journal of Medicine, 1997
- Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic childrenEuropean Journal of Clinical Pharmacology, 1996
- Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsyThe Lancet, 1995
- Lamotrigine in Treatment of 120 Children with EpilepsyEpilepsia, 1994
- Vigabatrin in the Treatment of Childhood Epilepsies: A Single‐Blind Placebo‐Controlled StudyEpilepsia, 1989
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989